MitoPBN

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameMitoPBN

Drug Alias Namemitochondrial-targeted phenybutylnitrone (Antipodean Pharmaceuticals)mitochondria-targeted spin-trap agent (Anitopodean Pharmaceuticals)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFree radicals scavengers

TargetsFree radicals

Therapy Area/IndicationsMitochondrial Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAntipodean Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAntipodean Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsMitochondrial Diseases

Other Information

ATC CodeN/A